Intellia says FDA accepted BLA for lonvo-z
Intellia said the FDA accepted the BLA for lonvo-z, granted Priority Review and set a PDUFA action date of March 10, 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.